Breast Cancer Biomarkers: Towards Targeted Therapy

Day 2, Thursday 8th November 2018

8:30-10:00 Breast Cancer Biomarkers: Towards Targeted Therapy
Moderators Dr. Giles Pages and Dr. Suad M. Ben Amer
8:30-9:00 “Deficiency of the zinc finger binding protein, tristetraprolin, is a hallmark of cancer”
Special Presentation: Dr. Khalid S. A. Khabar, PhD; KFSH&RC, Riyadh, Saudi Arabia
9:00-9:30 "Resistance to lysosomotropic drugs used for kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5”
Keynote Speaker: Dr. Gilles Pages, PhD; University of Nice Sophia Antipolis, France
9:30-9:50 “MicroRNAs: Puzzling molecules in Cancer Therapy... Are we ready?
Speaker: Dr. Amal Qattan, PhD; KFSH&RC, Riyadh, Saudi Arabia
9:50-10:00 “The RNA-binding protein AUF-1 induces stemness in breast cancer cells”
Short Talk: Ms. Manar AlAhmari, BSc, KFSHRC, Riyadh, Saudi Arabia
10:00-10:10 Targeting nucleotide excision repair by miR-145 in breast cancer; a novel therapeutic strategy to overcome chemotherapy resistance”
Short Talk: Dr. Homood Moqbel As Sobeai, PhD, College of Pharmacy, KSU, Riyadh, Saudi Arabia
10:10-10:15 Breast Cancer Survivor (Zahra)
10:15-10:45 Poster Session

Speakers

Dr. Khalid S. A. Khabar, PhD

Lecture Title: "Deficiency of the zinc finger binding protein, tristetraprolin, is a hallmark of cancer"

Gilles Pages, PhD

Lecture Title: "Primary Resistance to Targeted Therapy: A Common Mechanism Between Breast and Kidney Cancers"

Dr. Amal Qattan, PhD

Lecture Title: "MicroRNAs: Puzzling Molecules in Cancer Therapy... Are We Ready?"